{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:22:57Z","timestamp":1793139777317,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73088-y","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:24:29Z","timestamp":1779294269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multi-modal AI for comprehensive breast cancer prognostication"],"prefix":"10.1038","volume":"17","author":[{"given":"Jan","family":"Witowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken G.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cappadona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jailan","family":"Elayoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Choucair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6037-0714","authenticated-orcid":false,"given":"Elena Diana","family":"Chiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-0513","authenticated-orcid":false,"given":"Young-Joon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6039-1141","authenticated-orcid":false,"given":"Frederick","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Ostrovnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fernandez-Granda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Steinsnyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Ozerdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Abdulsattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafic","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0101-0131","authenticated-orcid":false,"given":"Anas M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6281-6795","authenticated-orcid":false,"given":"Nitya","family":"Thakore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sadic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-6451","authenticated-orcid":false,"given":"Theodore","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4463-9462","authenticated-orcid":false,"given":"Benjamin","family":"Swett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Rigau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-1805","authenticated-orcid":false,"given":"Andrew J.","family":"Clayburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0602-4666","authenticated-orcid":false,"given":"Valerie","family":"Speirs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Sojak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Muenst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-7507","authenticated-orcid":false,"given":"Daniel","family":"Baumhoer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-9831","authenticated-orcid":false,"given":"Jia-Wern","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2893-4687","authenticated-orcid":false,"given":"Haslina","family":"Makmur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-590X","authenticated-orcid":false,"given":"Soo-Hwang","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-2868","authenticated-orcid":false,"given":"Dovile","family":"Zilenaite-Petrulaitiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-1730","authenticated-orcid":false,"given":"Arvydas","family":"Laurinavicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2683-8157","authenticated-orcid":false,"given":"Brian D.","family":"Piening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-6977","authenticated-orcid":false,"given":"Carlo","family":"Bifulco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-2094","authenticated-orcid":false,"given":"Sun-Young","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Pak","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Hyun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8080-7960","authenticated-orcid":false,"given":"Adam","family":"Brufsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Esteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9632-6686","authenticated-orcid":false,"given":"Lajos","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"LeCun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof J.","family":"Geras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"73088_CR1","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik, S. et al. A multigene assay to predict recurrence Of Tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351, 2817\u20132826 (2004).","journal-title":"N. Engl. J. Med."},{"key":"73088_CR2","first-page":"147","volume":"4","author":"S Mook","year":"2007","unstructured":"Mook, S., Van\u2019t Veer, L. J., Rutgers, E. J., Piccart-Gebhart, M. J. & Cardoso, F. Individualization of therapy using Mammaprint: from development to the MINDACT Trial. Cancer Genomics Proteom. 4, 147\u2013155 (2007).","journal-title":"Cancer Genomics Proteom."},{"key":"73088_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-015-0129-6","volume":"8","author":"B Wallden","year":"2015","unstructured":"Wallden, B. et al. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. BMC Med. Genom. 8, 1\u201314 (2015).","journal-title":"BMC Med. Genom."},{"key":"73088_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jamaoncol.2019.4794","volume":"6","author":"JA Sparano","year":"2020","unstructured":"Sparano, J. A. et al. Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: a secondary analysis of the TAILORx randomized clinical trial. JAMA Oncol. 6, 367\u2013374 (2020).","journal-title":"JAMA Oncol."},{"key":"73088_CR5","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1001\/jamaoncol.2017.1261","volume":"3","author":"LJ Esserman","year":"2017","unstructured":"Esserman, L. J. et al. Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades. JAMA Oncol. 3, 1503\u20131510 (2017).","journal-title":"JAMA Oncol."},{"key":"73088_CR6","doi-asserted-by":"crossref","unstructured":"Pusztai, L. et al. Development and validation of RSClin N+ tool for hormone receptor-positive (HR+), HER2-negative (HER2-), node-positive breast cancer. J. Clin. Oncol. 42, 508 (2024).","DOI":"10.1200\/JCO.2024.42.16_suppl.508"},{"key":"73088_CR7","doi-asserted-by":"crossref","unstructured":"Miglietta, F. et al. 242MO Association of tumor-infiltrating lymphocytes (TILs) with recurrence score (RS) in patients with hormone receptor-positive (HR+)\/HER2-negative (HER2-) early breast cancer (BC): A translational analysis of four prospective multicentric studies. Ann. Oncol. 34, S280 (2023).","DOI":"10.1016\/j.annonc.2023.09.440"},{"key":"73088_CR8","unstructured":"Chen, T., Kornblith, S., Norouzi, M. & Hinton, G. A simple framework for contrastive learning of visual representations. In Proceedings of the 37th International Conference on Machine Learning, vol. 119 of Proceedings of Machine Learning Research, 1597\u20131607 (2020)."},{"key":"73088_CR9","doi-asserted-by":"crossref","unstructured":"He, K., Fan, H., Wu, Y., Xie, S. & Girshick, R. Momentum contrast for unsupervised visual representation learning. In CVPR (2020).","DOI":"10.1109\/CVPR42600.2020.00975"},{"key":"73088_CR10","unstructured":"Grill, J.B. et al. Bootstrap your own latent - a new approach to self-supervised learning. In Advances in Neural Information Processing Systems, 33, 21271\u201321284 (2020)."},{"key":"73088_CR11","doi-asserted-by":"crossref","unstructured":"He, K. et al. Masked Autoencoders Are Scalable Vision Learners. In CVPR, 16000\u201316009 (2022).","DOI":"10.1109\/CVPR52688.2022.01553"},{"key":"73088_CR12","doi-asserted-by":"crossref","unstructured":"Caron, M. et al. Emerging properties in self-supervised vision transformers. In Proc.IEEE\/CVF International Conference on computer vision, 965\u20139660 (2021).","DOI":"10.1109\/ICCV48922.2021.00951"},{"key":"73088_CR13","unstructured":"Oquab, M. et al. DINOv2: Learning robust visual features without supervision. Transactions on Machine Learning Research (2024)."},{"key":"73088_CR14","doi-asserted-by":"crossref","unstructured":"Vorontsov, E. et al. A foundation model for clinical-grade computational pathology and rare cancers detection. Nat. Med. 30, 2924\u20132935 (2024).","DOI":"10.1038\/s41591-024-03141-0"},{"key":"73088_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41591-024-02857-3","volume":"30","author":"RJ Chen","year":"2024","unstructured":"Chen, R. J. et al. Towards a general-purpose foundation model for computational pathology. Nat. Med. 30, 850\u2013862 (2024).","journal-title":"Nat. Med."},{"key":"73088_CR16","doi-asserted-by":"crossref","unstructured":"Wang, X. et al. A pathology foundation model for cancer diagnosis and prognosis prediction. Nature 634, 1\u20139 (2024).","DOI":"10.1038\/s41586-024-07894-z"},{"key":"73088_CR17","unstructured":"Garberis, I. et al. Deep learning allows assessment of risk of metastatic relapse from invasive breast cancer histological slides. Nat. Commun. 16, 5876 (2025)."},{"key":"73088_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01879-6","volume":"26","author":"A Sharma","year":"2024","unstructured":"Sharma, A. et al. Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images. Breast Cancer Res. 26, 123 (2024).","journal-title":"Breast Cancer Res."},{"key":"73088_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-022-01592-2","volume":"24","author":"G Fernandez","year":"2022","unstructured":"Fernandez, G. et al. Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years. Breast Cancer Res. 24, 1\u201311 (2022).","journal-title":"Breast Cancer Res."},{"key":"73088_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57283-x","volume":"16","author":"KM Boehm","year":"2025","unstructured":"Boehm, K. M. et al. Multimodal histopathologic models stratify hormone receptor-positive early breast cancer. Nat. Commun. 16, 2106 (2025).","journal-title":"Nat. Commun."},{"key":"73088_CR21","unstructured":"Cappadona, J. et al. Squeezing performance from pathology foundation models with chained hyperparameter searches. In NeurIPS 2024 Workshop: Self-Supervised Learning-Theory and Practice (2024)."},{"key":"73088_CR22","unstructured":"Dosovitskiy, A. et al. An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale. In International Conference on Learning Representations https:\/\/openreview.net\/forum?id=YicbFdNTTy (2021)."},{"key":"73088_CR23","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","DOI":"10.1038\/nature11412"},{"key":"73088_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello, G. et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell 163, 506\u2013519 (2015).","journal-title":"Cell"},{"key":"73088_CR25","doi-asserted-by":"crossref","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","DOI":"10.1038\/nature10983"},{"key":"73088_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47\u201354 (2016).","journal-title":"Nature"},{"key":"73088_CR27","doi-asserted-by":"publisher","unstructured":"Bifulco, C. et al. Identifying high-risk breast cancer using digital pathology images: a Nightingale Open Science dataset. Nightingale Open Science https:\/\/doi.org\/10.48815\/N5159B (2021).","DOI":"10.48815\/N5159B"},{"key":"73088_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","volume":"11","author":"KS Albain","year":"2010","unstructured":"Albain, K. S. et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.  Lancet Oncol. 11, 55\u201365 (2010).","journal-title":"Lancet Oncol."},{"key":"73088_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano, J. A. et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N. Engl. J. Med. 379, 111\u2013121 (2018).","journal-title":"N. Engl. J. Med."},{"key":"73088_CR30","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","volume":"385","author":"K Kalinsky","year":"2021","unstructured":"Kalinsky, K. et al. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N. Engl. J. Med. 385, 2336\u20132347 (2021).","journal-title":"N. Engl. J. Med."},{"key":"73088_CR31","doi-asserted-by":"crossref","unstructured":"Waks, A. et al. Assessment of the HER2DX assay in patients with ERBB2-positive breast cancer treated with neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab. JAMA Oncol. 9, 835\u2013840 (2023).","DOI":"10.1001\/jamaoncol.2023.0181"},{"key":"73088_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jama.2021.13304","volume":"326","author":"A Flanagin","year":"2021","unstructured":"Flanagin, A., Frey, T. & Christiansen, S. L. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 326, 621\u2013627 (2021).","journal-title":"JAMA"},{"key":"73088_CR33","doi-asserted-by":"crossref","unstructured":"Satpathy, Y. et al. Comparison of capture rates of the national cancer database across race and ethnicity. JAMA Netw. Open 6, e2350237 (2023).","DOI":"10.1001\/jamanetworkopen.2023.50237"},{"key":"73088_CR34","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","volume":"24","author":"S Paik","year":"2006","unstructured":"Paik, S. et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor\u2013positive breast cancer. J. Clin. Oncol. 24, 3726\u20133734 (2006).","journal-title":"J. Clin. Oncol."},{"key":"73088_CR35","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/sim.9717","volume":"42","author":"N Hartman","year":"2023","unstructured":"Hartman, N., Kim, S., He, K. & Kalbfleisch, J. D. Pitfalls of the concordance index for survival outcomes. Stat. Med. 42, 2179\u20132190 (2023).","journal-title":"Stat. Med."},{"key":"73088_CR36","doi-asserted-by":"crossref","unstructured":"Takahashi, M. et al. Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in patients with early triple-negative breast cancer: a secondary analysis of a randomized clinical trial. JAMA Netw. Open 6, e2342107 (2023).","DOI":"10.1001\/jamanetworkopen.2023.42107"},{"key":"73088_CR37","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMoa2112651","volume":"386","author":"P Schmid","year":"2022","unstructured":"Schmid, P. et al. Event-free survival with Pembrolizumab in early triple-negative breast cancer.  N. Engl. J. Med. 386, 556\u2013567 (2022).","journal-title":"N. Engl. J. Med."},{"key":"73088_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1200\/OP.22.00722","volume":"19","author":"CA Santa-Maria","year":"2023","unstructured":"Santa-Maria, C. A. Optimizing and refining immunotherapy in breast cancer. JCO Oncol. Pract. 19, 190\u2013191 (2023).","journal-title":"JCO Oncol. Pract."},{"key":"73088_CR39","unstructured":"Tolaney, S. et al. OptimICE-pCR: De-escalation of therapy in early-stage TNBC patients who achieve pCR after neoadjuvant chemotherapy with checkpoint inhibitor therapy (Alliance A012103) [abstract]. In Proceedings of the 2023 San Antonio Breast Cancer Symposium, vol. 84 (AACR, 2024)."},{"key":"73088_CR40","doi-asserted-by":"crossref","unstructured":"Stecklein, S. R. et al. NeoTRACT: Phase II trial of neoadjuvant tumor-infiltrating lymphocyte- and response-adapted chemoimmunotherapy for triple-negative breast cancer (TNBC). J. Clin. Oncol. 42, http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05645380 (2024).","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS629"},{"key":"73088_CR41","doi-asserted-by":"crossref","unstructured":"Spratt, D. E. et al. Artificial intelligence predictive model for hormone therapy use in prostate cancer. NEJM Evid. 2, EVIDoa2300023 (2023).","DOI":"10.1056\/EVIDoa2300023"},{"key":"73088_CR42","doi-asserted-by":"crossref","unstructured":"Spratt, D. E. et al. An AI-derived digital pathology-based biomarker to predict the benefit of androgen deprivation therapy in localized prostate cancer with validation in NRG\/RTOG 9408. J. Clin. Oncol. 40, 223 (2022).","DOI":"10.1200\/JCO.2022.40.6_suppl.223"},{"key":"73088_CR43","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/s41591-024-02993-w","volume":"30","author":"S Volinsky-Fremond","year":"2024","unstructured":"Volinsky-Fremond, S. et al. Prediction of recurrence risk in endometrial cancer with multimodal deep learning. Nat. Med. 30, 1962\u20131973 (2024).","journal-title":"Nat. Med."},{"key":"73088_CR44","doi-asserted-by":"crossref","unstructured":"Podany, E. L., Goldberg, P., Ma, C. X. & Davis, A. A. Improving the OncotypeDX ordering process in patients with ER+ HER2-early-stage breast cancer: A longitudinal QI project. JCO Oncol Pract. 20, 292 (2024).","DOI":"10.1200\/OP.2024.20.10_suppl.292"},{"key":"73088_CR45","doi-asserted-by":"crossref","unstructured":"Hartzell, M. et al. Improving oncotype dx turnaround time for timeliness of adjuvant therapy: A single-system, multi-site quality improvement study in early-stage hr-positive breast cancer. JCO Oncol Pract. 21, 464 (2025).","DOI":"10.1200\/OP.2025.21.10_suppl.464"},{"key":"73088_CR46","unstructured":"Freedman, B. Q. Cms posts final prices for new lab tests (November 2023). https:\/\/www.discoveriesinhealthpolicy.com\/2023\/11\/cms-posts-final-prices-for-new-lab.html (2023)."},{"key":"73088_CR47","doi-asserted-by":"crossref","unstructured":"Berdunov, V. et al. Cost-effectiveness analysis of the Oncotype Dx Breast Recurrence Score\u00ae test from a US societal perspective. ClinicoEconomics Outcomes Res. 16, 471\u2013482 (2024).","DOI":"10.2147\/CEOR.S449711"},{"key":"73088_CR48","unstructured":"Geras, K. & Sutton, C. Multiple-source cross-validation. In Proceedings of the 30th International Conference on Machine Learning, vol. 28 of Proceedings of Machine Learning Research (2013)."},{"key":"73088_CR49","unstructured":"Shao, D. et al. Do multiple instance learning models transfer? In the Forty-second International Conference on Machine Learning https:\/\/openreview.net\/forum?id=hfLqdquVt3 (2025)."},{"key":"73088_CR50","doi-asserted-by":"crossref","unstructured":"Dietterich, T. G. Ensemble methods in machine learning. In Multiple Classifier Systems, 1-15 (Springer Berlin Heidelberg, Berlin, Heidelberg, 2000).","DOI":"10.1007\/3-540-45014-9_1"},{"key":"73088_CR51","unstructured":"Bergstra, J. & Bengio, Y. Random search for hyper-parameter optimization. J. Mach. Learn. Res. 13, 281\u2013305 (2012)."},{"key":"73088_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41591-023-02643-7","volume":"30","author":"M Amgad","year":"2024","unstructured":"Amgad, M. et al. A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer. Nat. Med. 30, 85\u201397 (2024).","journal-title":"Nat. Med."},{"key":"73088_CR53","doi-asserted-by":"crossref","unstructured":"Nimgaonkar, V. et al. Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer. Cell Rep. Med. 4, 101013 (2023).","DOI":"10.1016\/j.xcrm.2023.101013"},{"key":"73088_CR54","doi-asserted-by":"crossref","unstructured":"Otsu, N. A Threshold selection method from gray-level histograms. IEEE Trans. Syst. Man Cybernet. 9, 62\u201366 (1979).","DOI":"10.1109\/TSMC.1979.4310076"},{"key":"73088_CR55","unstructured":"Kingma, D. P. & Ba, J. Adam: A Method for Stochastic Optimization. In ICLR (2015)."},{"key":"73088_CR56","unstructured":"Ilse, M., Tomczak, J. & Welling, M. Attention-based Deep Multiple Instance Learning. In International Conference on Machine Learning, 2127\u20132136 (PMLR, 2018)."},{"key":"73088_CR57","unstructured":"Prokhorenkova, L., Gusev, G., Vorobev, A., Dorogush, A. V. & Gulin, A. Catboost: unbiased boosting with categorical features. In Proc. Advances in Neural Information Processing Systems. 31, 6639\u20136649 (2018)."},{"key":"73088_CR58","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/sim.4780111409","volume":"11","author":"LJ Wei","year":"1992","unstructured":"Wei, L.J. The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis. Stat. Med. 11, 1871\u20131879 (1992).","journal-title":"Stat. Med."},{"key":"73088_CR59","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell","year":"1982","unstructured":"Harrell, F. E., Califf, R. M., Pryor, D. B., Lee, K. L. & Rosati, R. A. Evaluating the yield of medical tests. JAMA 247, 2543\u20132546 (1982).","journal-title":"JAMA"},{"key":"73088_CR60","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman, D. G. & Royston, P. The cost of dichotomising continuous variables. Bmj 332, 1080 (2006).","journal-title":"Bmj"},{"key":"73088_CR61","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163\u2013170 (1966).","journal-title":"Cancer Chemother. Rep."},{"key":"73088_CR62","doi-asserted-by":"crossref","unstructured":"Shen, Y., Luo, Y., Shen, D. & Ke, J. RandStainNA: Learning stain-agnostic features from histology slides by bridging stain augmentation and normalization. In MICCAI (2022).","DOI":"10.1007\/978-3-031-16434-7_21"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73088-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:07:54Z","timestamp":1783328874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73088"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73088-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.W., K.Z., J.C., C.F.G., F.S., Z.S., A.B., F.J.E., Y.L.C., and K.J.G. are equity holders of Ataraxis AI. IO served as a consultant for Ataraxis AI. New York University (NYU) maintains financial and intellectual property interests in Ataraxis AI that are pertinent to the research presented in this manuscript. J.W. and K.J.G. are inventors on a US patent application filed corresponding to some of the methodological aspects of this work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5879"}}